Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,639 | -24,459 | -12,966 | -11,204 | -12,344 |
| Depreciation Amortization | 2,109 | 1,677 | 993 | 955 | 912 |
| Income taxes - deferred | 53 | -887 | -63 | N/A | N/A |
| Accounts receivable | 213 | 1,392 | 465 | -727 | -58 |
| Other Working Capital | 3,649 | -3,673 | -187 | -641 | 2,946 |
| Other Operating Activity | -323 | 11,870 | 631 | 103 | 1,501 |
| Operating Cash Flow | $-11,938 | $-14,080 | $-11,127 | $-11,514 | $-7,043 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,710 | N/A | N/A | N/A | N/A |
| PPE Investments | -149 | -48 | -122 | -142 | -47 |
| Net Acquisitions | N/A | 1,611 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -4,500 | -18,603 | -24,000 |
| Sale Of Investment | N/A | N/A | 8,000 | 16,400 | 9,300 |
| Purchase Sale Intangibles | -125 | -117 | -462 | -504 | -1,318 |
| Other Investing Activity | -125 | -117 | -462 | -504 | -1,319 |
| Investing Cash Flow | $11,436 | $1,446 | $2,916 | $-2,849 | $-16,065 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 12,221 | N/A | N/A |
| Common Stock Issued | 2,483 | 28,765 | 1 | 16,290 | 14,326 |
| Dividend Paid | N/A | N/A | N/A | -23 | -132 |
| Other Financing Activity | -12,176 | -161 | -61 | 36 | 0 |
| Financing Cash Flow | $-9,693 | $28,604 | $12,161 | $16,303 | $14,193 |
| Exchange Rate Effect | -103 | 211 | -86 | -11 | 70 |
| Beginning Cash Position | 30,296 | 14,115 | 10,251 | 8,322 | 17,167 |
| End Cash Position | 19,999 | 30,296 | 14,115 | 10,251 | 8,322 |
| Net Cash Flow | $-10,298 | $16,181 | $3,864 | $1,929 | $-8,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,938 | -14,080 | -11,127 | -11,514 | -7,043 |
| Capital Expenditure | -182 | -48 | -122 | -142 | -47 |
| Free Cash Flow | -12,119 | -14,129 | -11,248 | -11,655 | -7,090 |